fr

EN DE

fr

EN DE

Publications

2075 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cancers

Sani S

Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin.

2022

Journal of biomolecular structure & dynamics

Oubella A

Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies.

2022

Cancer chemotherapy and pharmacology

Reda M

Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.

2022

BMC surgery

Gomes David M

Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups.

2022

Annals of surgical oncology

Paquette B

Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.

2022

Experimental dermatology

Zanella A

PD-L1 in circulating exosomes of Merkel cell carcinoma.

2022

British journal of cancer

Ychou M

Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.

2022

BMC cancer

Vachenc S

OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.

2022

Cancers

Ben Khelil M

Harnessing Antitumor CD4 T Cells for Cancer Immunotherapy.

2022

European journal of cancer (Oxford, England : 1990)

Stouvenot M

Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.